Trade CTMX stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
CytomX Therapeutics, Inc. (CTMX) is trading at US$3.20, down 2.74% today as of Sep 14, 16:00 EDT. The company has a market capitalisation of US$714.71M. Over the past 52 weeks, CTMX has traded between US$1.90 and US$8.21. On Syfe you can trade CTMX with $0 commission and add it to your watchlist.
| Previous close | US$3.29 |
|---|---|
| Market cap | US$714.71M |
| 52-week range | US$1.90 – US$8.21 |
| Volume | 6.13M |
| Exchange | US |
Add to Watchlist
Set Price Alert
CytomX Therapeutics, Inc.
CytomX Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies to address unmet need in oncology. The firm focuses on the field of antibody masking technologies through the development of its Probody therapeutic platform. The company was founded by Frederick W. Gluck, Nancy E. Stagliano, and Patrick S. Daugherty in February 2008 and is headquartered in South San Francisco, CA.
Year: 2015
CytomX Therapeutics Expands Cancer Therapy Partnership With Regeneron; Shares Rise
Jun 3, 1:21 PM · MT Newswires
Wolfe Research Initiates CytomX Therapeutics With Outperform Rating
May 19, 12:12 PM · MT Newswires
-- Earnings Flash (CTMX) CytomX Therapeutics, Inc. Reports Q1 Revenue $10.3M, vs. FactSet Est of $4.7M
May 7, 8:28 PM · MT Newswires
Cytomx Therapeutics Insider Sold Shares Worth $764,138, According to a Recent SEC Filing
Mar 20, 8:25 AM · MT Newswires
CytomX Therapeutics, Inc. (CTMX) stock is trading at US$3.20, -2.74% from the previous close of US$3.29.
The market cap for CytomX Therapeutics, Inc. (CTMX) stock is approximately US$714.71M.
The 52-week high for CytomX Therapeutics, Inc. (CTMX) stock is US$8.21.
The 52-week low for CytomX Therapeutics, Inc. (CTMX) stock is US$1.90.
CytomX Therapeutics, Inc. (CTMX) does not currently pay a dividend.
Stay on top of CTMX
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
